同源康医药(02410.HK) 公布,接获非执行董事顾虹通知,其全资拥有的公司贝沃特医药技术(上海)于前日(20日)进行了一项场内交易,售出合共1万股公司H股股份,代价为每股14.99元,涉资14.99万元,于转让前并无根据上市规则附录C3第B.8段规定事先告知公司。顾虹H股实益权益股已从约2.20%降至约2.19%。根据上市规则附录C3第A.3段,董事于公司财务业绩刊发的任何日子及紧接公司截至...
Source Link同源康医药(02410.HK) 公布,接获非执行董事顾虹通知,其全资拥有的公司贝沃特医药技术(上海)于前日(20日)进行了一项场内交易,售出合共1万股公司H股股份,代价为每股14.99元,涉资14.99万元,于转让前并无根据上市规则附录C3第B.8段规定事先告知公司。顾虹H股实益权益股已从约2.20%降至约2.19%。根据上市规则附录C3第A.3段,董事于公司财务业绩刊发的任何日子及紧接公司截至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.